MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
F‐star Announces Collaborative Agreement with Denali Therapeutics for the Development of a Multispecific Antibody Platform to Deliver Therapeutics Across the Blood‐Brain Barrier.
Guest UserAugust 25, 2016
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

miRagen Therapeutics Appoints Kevin Koch, Ph.D., to Its Board of Directors.

Guest UserSeptember 9, 2016
Next

miRagen Therapeutics Initiates First Clinical Trial for MRG-106 in Lymphoma Patients.

Guest UserMarch 2, 2016

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact